The science of what we eat is failing us– The New York Times, June 19, 2023 Harvard University medical researchers explain why the state of nutrition research is so poor, and how the problems afflict much of the research into dietary and lifestyle claims around things like coffee, wine, dark chocolate, fad diets, the amount you exercise—you name it. Medical researchers need to take advantage…
Last call to submit stories for “In Pursuit of Wellness” film series Last year, the Global Wellness Institute and BBC StoryWorks launched “In Pursuit of Wellness: The Art & Science of Living Well” to great acclaim. To date, the series has won four awards, generated a staggering 5 million views, 500,000 page visits to the series site on BBC.com and over 4 million social engagements. The…
Celebrities are talking openly about menopause. Why won’t the healthcare industry?Social media is fueling enthusiasm for new weight loss drugs. Are regulators watching?– Salon, May 21, 2023 The public discourse around menopause has dramatically improved, thanks partly to outspoken celebrities helping to change the paradigm. But all women desperately need more healthcare resources for menopause: affordable, effective, and widely available therapies and educational resources. We…
The War on Obesity Heats Up: Big Food Drives Problem, Big Pharma Cashes In By Solving It By Thierry Malleret, economist The war on obesity is now ramping up, with new research estimating that the global cost will be a crippling $4 trillion by 2035. Telling: Novo Nordisk, the maker of obesity drug Wegovy, has seen such huge recent sales that it just overtook Nestlé…
GWI Previews Its Wellness Policy Toolkit on the Built Environment At the Wellness Real Estate Symposium held May 2 in Manhattan, 35-plus experts took the stage to discuss the future of “building well.” GWI researchers previewed their Wellness Policy Toolkit: The Built Environment. Because the $275 billion wellness real estate market is out of reach for the vast majority of people, GWI presented the case…
Social media is fueling enthusiasm for new weight loss drugs. Are regulators watching?– CBS News, April 18, 2023 An in-depth look at the non-stop hype (and even misinformation) around the new weight loss drugs Ozempic and Wegovy. And at how competition to claim a market that could be worth $100 billion a year for drugmakers alone has triggered a wave of advertising that has provoked the concern…
Notifications
